PedAM
Pediatric Disease Annotations & Medicines
| Disease | thromboembolism |
| Phenotype | C0007113|rectal cancer |
| Sentences | 9 |
| PubMedID- 19652579 | thromboembolic events in patients with colorectal cancer receiving the combination of bevacizumab-based chemotherapy and erythropoietin stimulating agents. |
| PubMedID- 22671575 | Incidence of thromboembolic events in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy. |
| PubMedID- 22900573 | Preoperative plasma d-dimer predicts 1-year survival in colorectal cancer patients with absence of venous thromboembolism (vte): a prospective clinical cohort study. |
| PubMedID- 21273347 | Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab. |
| PubMedID- 25209947 | Ibd patients undergoing surgery have a higher risk of venous thromboembolic disease than patients with colorectal cancer, and current guidelines recommend that they should receive prophylaxis with heparin. |
| PubMedID- 26217616 | Occurrence and prognosis of symptomatic venous thromboembolism in colorectal cancer surgery patients. |
| PubMedID- 19697164 | Management of venous thromboembolism in colorectal cancer patients treated with bevacizumab. |
| PubMedID- 24977288 | Variation in the risk of venous thromboembolism in people with colorectal cancer: a population-based cohort study from england. |
| PubMedID- 22859911 | Risk of venous thromboembolism in people with colorectal cancer, with pooled incidence rates and 95% confidence intervals obtained from random effects meta-analysis. |
Page: 1